Stock Events

Stock Events

Cullinan Therapeutics (CGEM) Q2 2024 Earnings

15MayConfirmed

Q2 2023

Q3 2023

Q4 2023

Q2 2024

-0.99

-0.84

-0.69

-0.54

Details

Expected EPS

-0.989867

Actual EPS

-0.86

Surprise EPS

0.13

Surprise Percent

+13.12%

Description

Cullinan Therapeutics (CGEM) has reported earnings of -0.86 per share for Q2 2024.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.